HB 2497 addresses the 70% rise in child fatalities and near-fatal abuse cases by supporting families involved with child welfare services. The bill requires the state to provide legal counsel and parent allies for pregnant individuals or new parents at risk of child removal, assign public health nurses to parents of children under four with active investigations, and expand the Parent-Child Assistance Program in high-need areas for families with substance use issues. It also mandates specialized training for child welfare supervisors on safety assessments and improves connections to community services. These changes aim to keep children safe at home while addressing root causes like substance use and lack of support.
HB 2560 creates a new state-funded model to support residential pediatric recovery centers that provide nonmedical care for infants born with prenatal substance exposure (e.g., to opioids or methamphetamines) and their families. The bill requires the state to seek federal approval for direct payments to these centers by July 2027 and to provide interim grants using opioid settlement funds until then. It aims to replace lengthy hospital stays in neonatal intensive care units with a family-centered approach that promotes bonding and helps keep infants with parents in recovery. The new funding will cover services like caregiver coaching, bonding activities, and transition planning to support safe home reunification.
HB 2331 requires Washington's Medicaid program to cover specific pediatric and behavioral health screenings and assessments, including autism and developmental delay screenings for children, annual depression screenings for youth aged 12-18, maternal depression screenings for mothers of infants under six months, and mental health assessments for children under five, all subject to available funding. The bill also explicitly prohibits cuts to life-sustaining services like prescription medications, oxygen, and respiratory supplies. This directly affects children, adolescents, and families enrolled in Medicaid by ensuring continued access to these critical health services. The law amends existing Medicaid coverage rules to prevent reductions in pediatric care access, focusing on evidence-based screening requirements.
Washington State's SB 6094 creates a framework for funding specialized pediatric transitional care facilities to replace extended hospital stays for infants exposed to substances like opioids during pregnancy. The bill directly affects substance-exposed infants and their parents, aiming to support bonding and recovery by providing non-hospital care in a nurturing environment instead of neonatal intensive care units. Key provisions require the Health Care Authority to study funding models using federal/state resources, submit a report by November 2026, and provide temporary grants to a pilot facility using opioid settlement funds until the study concludes. The bill expires December 31, 2028, and focuses on concrete policy changes to reduce costs and prevent foster care placement.
This bill requires most health insurance plans (excluding public employee plans) to cover intravenous immunoglobulin therapy for children diagnosed with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) or PANS (pediatric acute-onset neuropsychiatric syndrome) starting January 2027. It mandates coverage for three initial monthly treatment courses and ongoing care as medically necessary, after less intensive treatments fail or aren't tolerated. The law prohibits insurers from denying coverage based on prior treatment history, diagnostic name changes, requiring ineffective symptom-only therapies first, or restricting coverage inconsistent with medical guidelines. It also ensures coverage for out-of-state treatment when local care isn't available.
SB 5867 requires Washington’s state health authority to develop a mobile pregnancy application through a competitive bidding process, targeting Medicaid-eligible pregnant and postpartum women. The app must provide multilingual educational resources, connect users to state health programs (like perinatal substance use services), and be available on Android and iOS. Key requirements include collecting anonymized usage data (e.g., daily users, engagement with Washington-specific resources) and ensuring clinical standards for content. The bill aims to improve awareness of maternal health programs but does not change Medicaid eligibility or funding. The state must issue a request for proposals within 180 days of the bill’s effective date.
HB 1741 requires most Washington health insurance plans (excluding public employee plans) to cover intravenous immunoglobulin (IVIG) therapy for children diagnosed with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) or PANS (pediatric acute-onset neuropsychiatric syndrome). Plans must cover three initial monthly IVIG treatments plus additional courses as medically necessary, but only after two or more less intensive treatments have been tried without success (e.g., ineffective, intolerable, or failing to improve symptoms). A pediatric subspecialist consultation is mandatory, and patients must be reevaluated every three months. The law applies to health plans renewed on or after January 1, 2026.
HB 1049 creates a state-funded stipend program to help registered nurses cover costs for training as specialized sexual assault nurse examiners (SANEs). The program reimburses up to $2,500 per nurse for training fees, materials, travel, lodging, and meals. It applies to nurses seeking certification for adult/adolescent or pediatric care, subject to available state funding. The stipend aims to increase the number of qualified SANEs by reducing financial barriers to training.
